| MR编号 | SE/H/2448/001 |
|---|
| 药品名称 | Bupivacaine Spinal Heavy Aguettant |
|---|
| 活性成分 | - Bupivacaine hydrochloride 5.0 mg/ml
|
|---|
| 剂型 | Solution for injection |
|---|
| 上市许可持有人 | Laboratoire Aguettant
1 Rue Alexander Fleming, Lyon 69007, France |
|---|
| 参考成员国 - 产品名称 | Sweden (SE) Bupivacaine Spinal Heavy Dextreg |
|---|
| 互认成员国 - 产品名称 | - Germany (DE)
Bupivacain Spinal hyperbar Dextreg - Finland (FI)
- Denmark (DK)
Bupivacaine Aguettant - Belgium (BE)
Bupivacaine Glucose Aguettant 5 mg/ml oplossing voor injectie - Netherlands (NL)
Bupivacaïne Glucose Aguettant 5 mg/ml oplossing voor injectie - Luxembourg (LU)
- Iceland (IS)
- Ireland (IE)
- Austria (AT)
- Spain (ES)
- Portugal (PT)
- Italy (IT)
- Norway (NO)
|
|---|
| 许可日期 | 2024/12/03 |
|---|
| 最近更新日期 | 2025/05/08 |
|---|
| 药物ATC编码 | | 申请类型 | - TypeLevel1：Abridged
- TypeLevel2：Initial Application
- TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
- TypeLevel4：Chemical Substance
- TypeLevel5：Prescription Only
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|
|
|---|